Zebra Capital Management LLC Puma Biotechnology, Inc. Transaction History

Zebra Capital Management LLC

  • $20 Million
  • Q1 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$2.13 - $3.24 $53,373 - $81,187
-25,058 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$2.85 - $6.58 $26,325 - $60,779
-9,237 Reduced 26.93%
25,058 $76,000
Q3 2021

Nov 15, 2021
BUY
$6.63 - $9.39 $22,475 - $31,832
3,390 Added 10.97%
34,295 $240,000
Q2 2021

Aug 16, 2021
SELL
$8.98 - $11.6 $29,975 - $38,720
-3,338 Reduced 9.75%
30,905 $284,000
Q1 2021

May 17, 2021
BUY
$9.38 - $13.63 $321,199 - $466,732
34,243 New
34,243 $333,000

Others Institutions Holding PBYI

# of Institutions
98
Shares Held
30.5M
Call Options Held
73.5K
Put Options Held
18.5K
View Full List

About PUMA BIOTECHNOLOGY, INC.

PBYI Quotes by TradingView
  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $118M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Zebra Capital Management LLC Portfolio

Follow Zebra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zebra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email